Overseas Network, Macau, February 24th (Reporter Fu Zimei) “The function of oral medicine for new coronary pneumonia is mainly to reduce the replication of the virus in the patient’s body as soon as possible and reduce the risk of aggravation, and it is mainly suitable for the population. For those who have not been vaccinated and have risk factors such as old age, obesity, chronic diseases, etc., the Health Bureau is formulating guidelines for the use of oral medicines for the treatment of new coronary pneumonia.” At the Macao SAR New Coronavirus Infection Response Coordination Center (hereinafter referred to as the Response Coordination Center) At the press conference held this afternoon, Liang Yihao, Director of the Infectious Disease Prevention and Control Division of the Center for Disease Control and Prevention, Health Bureau, made the above remarks on the drug issue of public concern.
Liang Yihao first announced that as of February 24, Macau had a total of 80 confirmed cases of new coronary pneumonia, a total of 0 deaths, and a total of 79 discharged. No medical staff were infected. A total of 31 asymptomatic infections have been reported, all of which are imported cases.
On the progress of purchasing oral medicines for COVID-19, which is a public concern, Liang Yihao said that there are two types of injection antiviral medicines in Macao, one is used to treat mild to moderately diagnosed patients, and the other is used to treat patients with mild to moderate cases. For severely diagnosed patients, Chinese patent medicines are reserved for treatment. At present, there are mainly two oral medicines produced by Merck & Co. and Pfizer in the world for the treatment of new coronary pneumonia. The Health Bureau is already purchasing these two medicines. Arrived in Australia at the beginning of the season.
In terms of vaccination, as of 4:00 pm on the 24th, Macau has received a total of 1,092,080 doses of the new crown vaccine. Recently, the number of appointments at the Macau vaccination station has increased significantly, from more than 1,000 doses per day to 3,000 doses. Among them, the third dose accounted for 2/3, and the number of adolescents, children or people over 60 years old who received the first dose also increased significantly. She stressed that the current vaccination rate in Macau is still not ideal, and once again called on those who are eligible to be vaccinated to get vaccinated as soon as possible. Statistics from Hong Kong show that the fatality rate between vaccinated and unvaccinated is 18 times;